StonvexLoading…
StonvexStonvexStonvexCore line items from CMC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-08-31 | Annual 2024 2024-08-31 | Annual 2023 2023-08-31 | Annual 2022 2022-08-31 |
|---|---|---|---|---|
Revenue | $7.80B | $7.93B | $8.80B | $8.91B |
Operating Income | $107.55M | $635.67M | $1.12B | $1.52B |
Net Income | $84.66M | $485.49M | $859.76M | $1.22B |
EPS (Diluted) | $0.74 | $4.14 | $7.25 | $9.95 |
Total Assets | $7.17B | $6.82B | $6.64B | $6.24B |
Total Liabilities | $2.98B | $2.52B | $2.52B | $2.95B |
Cash & Equivalents | $1.05B | $859.55M | $595.72M | $679.24M |
Free Cash Flow OCF − CapEx | $312.25M | $575.44M | $737.44M | $250.32M |
Shares Outstanding | 111.19M | 114.10M | 116.52M | 117.50M |